Skip to main content
Analytics and reporting

The panel as a single rollup, plus reports AriaMD writes for you.

Outcomes at the cohort level, practice performance at the workspace level, and study-grade synthesis on demand. Available on Provider+; some clinical-study and custom-export modes are enterprise.

Outcomes at the cohort level

The trajectory across a cohort, not just one chart.

Treatment-outcome trends from PHQ-9, GAD-7, COWS, and any custom scale you score. Switch cohort to see the same view for depression, anxiety, MAT, TMS, and Spravato. Built from the same signed encounters that drive each chart, so the numbers match the notes by definition.

nextvisit.app/analytics/outcomes
Wk 0Wk 4Wk 8Wk 12Wk 16ResponseRemission
PHQ-9 6.2at week 16, mean
66% lowervs baseline
Depressioncohort selected

Response and remission bands track standard cutoffs; click a cohort pill to swap the scale. Any aggregate is drillable to the patients underneath it.

Practice performance

Active panel, no-show rate, NPS, days in AR, top meds, top diagnoses.

The workspace-level rollup. Hover the diagnosis donut to filter the top-medications bar by indication. KPIs animate up on first view and refresh on any chart change.

nextvisit.app/analytics/practice
0
Active panel
across all providers
0.0%
No-show rate
last 30 days
0
Net promoter
clinician NPS
0
Days in AR
mean across payers
Top medications
  • Sertraline312
  • Bupropion254
  • Lamotrigine198
  • Vyvanse174
  • Lithium142
  • Buspirone121
Top diagnoses
  • Depression38%
  • Anxiety27%
  • ADHD14%
  • Bipolar11%
  • Other10%
AI review and data evaluation

Workspace data, written up like a study.

Synthesis at clinical-study level: sample size, methods, results, and the source encounters and codes the model pulled from. AriaMD does the heavy work; you read the abstract.

nextvisit.app/analytics/reports/mat-weekly
Workspace report · weekly

MAT outcomes, week ending 04-19-2026

n = 312 active inductions generated by AriaMD cohort 2024-Q1 to 2026-Q1

Abstract

Across 312 buprenorphine inductions over 8 quarters, retention at 90 days was 78%, with COWS reduction of 9.4 (95% CI 8.7 to 10.1) from baseline. Concurrent counseling participation averaged 71% (n=222 of 312). 14 inductions were terminated for diversion concerns; 7 of 14 transitioned to a higher level of care.

Methods

Retrospective analysis of all signed encounters tagged MAT in the workspace. COWS scores, UDS results, and counseling attendance pulled from the structured fields on each visit note. No free-text mining; results derive from the same fields the chart uses.

Results

  • Retention 90 days: 78% (243 of 312)
  • COWS reduction baseline to wk 12: 9.4 (CI 8.7 to 10.1)
  • UDS positive for prescribed buprenorphine at wk 12: 92%
  • Counseling adherence: 71% mean across cohort
  • Adverse events: 4 documented, 0 serious
Sources: 5,847 signed encounters · 312 charts referenced · ICD-10 F11.10, F11.20, F11.21 · ISO/IEC 42001 governed

Every claim links back to the underlying encounters. Numbers are not generated; they are counted from structured fields on signed notes. Enterprise unlocks longer cohort windows, multi-workspace pooling, and custom CI methods.

AriaMD-authored reports

Scheduled reports, delivered in any format you specify.

Write a prompt; pick a cadence and a delivery target. AriaMD runs the analysis and emails the result as a PDF, CSV, JSON, Markdown, or plain email body. Same engine that runs in the chart, run unattended.

nextvisit.app/automations/scheduled-report
AriaMD promptRecurring · Mon 09:00

PatientsEncountersDocumentsWeb search
DeliveryPDF · branded
  • Cadence: daily, weekday, weekly, monthly, or event-triggered
  • Output: PDF, CSV, JSON, Markdown, plain email, or any layout you can describe in the prompt
  • Delivery: email to a clinician or distribution list, automation event, or webhook
  • Tools: Patients and Encounters on by default; Documents and web search opt in
  • Spec: 10,000 prompt characters, four intelligence levels, scoped tools per task
What you need to run it

Provider+ for the dashboards and scheduled reports.

Outcomes, practice performance, and AriaMD-authored reports ship on Provider+. Enterprise unlocks the clinical-study mode, multi-workspace pooling, custom export formats, brand templates, and longer cohort windows.

See pricing Talk to sales for enterprise
See your panel as a single rollup

Twenty minutes. We open one of your real workspaces (or a sample) and walk the analytics view.

Outcomes by cohort, practice KPIs, a study-grade rollup, and one AriaMD-scheduled report wired to your inbox. You leave knowing whether reporting at this level changes how you run the practice.

Book a demo Talk to sales
Live in 2 weeks or less BAA signed by default 30-day money back